Jack Castle

Company: Ochre Bio

Job title: Head of Corporate Development

Seminars:

Panel & Audience Discussion: Collaborative Strategies for Advancing Antifibrotic Drug Development Across Diverse Disease Indications 5:00 pm

This panel discussion gathers experts from across the various disease indications to discuss what is needed to collectively advance antifibrotic drug development across the broad spectrum of diseases. Expect coverage of: With an increase recognition of the complexity and heterogeneity of fibrotic diseases, will combination therapies be necessary to secure clinical efficacy above the current…Read more

day: Day One

Shaping the Future of Antifibrotic Therapeutics with Exploration of Expansion Opportunities & Key Considerations 4:00 pm

This session will explore and evaluate emerging trends, identify innovative approaches to differentiate products and strategic insights on how to advance antifibrotic drug development and patient care across a broad spectrum of diseases. Examine the driving factors behind progress and how best to capitalize on these to explore your future expansion strategies.Read more

day: Day One

Leveraging Human Tissue Models for Discovery & Development: A Novel Approach to Preclinical Development 8:30 am

Examining human-centric discovery with deep phenotyping and RNA chemistry Uncovering ex-vivo human-organ perfusion models for the identification, characterization and validation of late-stage liver disease targetsRead more

day: Day One